Jump Financial »

Tourmaline Bio shares owned by Jump Financial

Quarter-by-quarter ownership of Tourmaline Bio (TRML) shares owned by Jump Financial from 13F filings

Historical chart of Jump Financial investment in Tourmaline Bio

Tip: Access up to 7 years of quarterly data

All positions including Tourmaline Bio held by Jump Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tourmaline Bio by Jump Financial

Quarter filed Position value Share count Share price at filing
2025-03-31 $318k 21k 15.21
2024-06-30 $357k 28k 12.86
2023-12-31 $380k 15k 26.18

More positions owned by Jump Financial

Invesco QQQ Trust Series 1 Etf (QQQ)
iShares Russell 2000 ETF Etf (IWM)
NVIDIA Corp Common Stock (NVDA)
SPDR S&P 500 ETF Trust Etf (SPY)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Alphabet Common Stock (GOOGL)
iShares iBoxx $ High Yield Corporate Bond ETF Etf (HYG)
Amazon.com Common Stock (AMZN)
Meta Platforms Common Stock (META)
Consumer Discretionary Select Sector SPDR Fund Etf (XLY)
Broadcom Common Stock (AVGO)
iShares U.S. Treasury Bond ETF Etf (GOVT)
Netflix Common Stock (NFLX)
Palantir Technologies Common Stock (PLTR)

View all positions for Jump Financial

Top funds holding Tourmaline Bio

venBio Select Advisor
QVT Financial
BlackRock
TCG Crossover Management
Pfizer
Vanguard Group
Fil
Magnetar Financial
Qiming U.S. Ventures Management
Vivaldi Asset Management
TIG Advisors
Vivo Capital
Alliancebernstein
Highland Capital Management Fund Advisors
Geode Capital Management

View all funds holding Tourmaline Bio